These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27936348)

  • 1. Current prospects and future challenges for nasal vaccine delivery.
    Yusuf H; Kett V
    Hum Vaccin Immunother; 2017 Jan; 13(1):34-45. PubMed ID: 27936348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Trends and Future Challenges of Nanovaccine Delivery
    Dewangan HK; Raghuvanshi A; Shah K
    Curr Drug Targets; 2023; 24(3):261-273. PubMed ID: 36475350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal delivery of nanoparticle-based vaccines.
    Marasini N; Skwarczynski M; Toth I
    Ther Deliv; 2017 Jan; 8(3):151-167. PubMed ID: 28145824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal vaccines.
    Davis SS
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):21-42. PubMed ID: 11516777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomineralized vaccine nanohybrid for needle-free intranasal immunization.
    Wang X; Yang D; Li S; Xu X; Qin CF; Tang R
    Biomaterials; 2016 Nov; 106():286-94. PubMed ID: 27575530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity.
    Teng Z; Meng LY; Yang JK; He Z; Chen XG; Liu Y
    J Control Release; 2022 Nov; 351():456-475. PubMed ID: 36174803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasal vaccines].
    Kido H; Mizuno D; Takei T
    Nihon Rinsho; 2008 Oct; 66(10):1881-7. PubMed ID: 18939485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing efficacy of mucosal vaccines.
    Gebril A; Alsaadi M; Acevedo R; Mullen AB; Ferro VA
    Expert Rev Vaccines; 2012 Sep; 11(9):1139-55. PubMed ID: 23151169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccination--an old but still vital strategy.
    Długońska H; Grzybowski M
    Ann Parasitol; 2012; 58(1):1-8. PubMed ID: 23094329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.
    Noh YW; Hong JH; Shim SM; Park HS; Bae HH; Ryu EK; Hwang JH; Lee CH; Cho SH; Sung MH; Poo H; Lim YT
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7684-9. PubMed ID: 23765547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
    Vyas SP; Gupta PN
    Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.